A comprehensive view of men's health issues. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
Olympus launches new ESG-410 electrosurgical generator to treat non-muscle-invasive bladder cancer, enlarged prostate; 82,000 new cases of bladder cancer will be diagnosed this year according to American Cancer Society
Published:
June 05, 2023
by Olympus America Inc.
|
AstraZeneca and MSD's Lynparza abiraterone and prednisone or prednisolone combination approved by FDA to treat BRCA-mutated metastatic castration-resistant prostate cancer; drug reduced disease progression or death by 76% compared to abiraterone alone
Published:
June 01, 2023
by AstraZeneca AB
|
Swiss diagnostics firm Proteomedix issues Labcorp exclusive license to develop, commercialize Proclarix PSA prostate cancer detection test in US; about 1 in 7 men will be diagnosed with prostate cancer during their lifetimes
Published:
May 22, 2023
by Associated Press
|
Olympus to feature minimally invasive technologies for enlarged prostate, kidney/bladder stone management, bladder cancer at AUA meeting; products include iTind BPH treatment, SOLTIVE SuperPulsed Thulium Fiber Laser, expanded stone management portfolio
Published:
April 25, 2023
by Olympus America Inc.
|
Novartis gains US approval to produce its radiopharmaceutical prostate cancer drug Pluvicto at its Millburn, New Jersey, facility; plant expected to begin contributing meaningful supply by Q3 2023
Published:
April 24, 2023
by SeeNews Pharmaceuticals
|
Ask us about our Consumer Wellness market view
Trending Chart
Interactive chart with headline count